The presence of the HLA-A-Bw4 isoform or HLA-B-Bw4-80T isoform is associated with the improved anti-tumour response to monoclonal antibody-based immunotherapy, as compared with HLA-B-Bw4-80I [43]. Here, HLA-B is linked to neoplasm.